Add To Watchlist
Share URL
About The Company
CEO
Mr. David Michael Cordani
Market Cap
99.95 Billion USD
Sector
Healthcare
Website
https://www.cigna.comLast Update
2/22/2024, 12:00:00 PM
Description
Cigna Corporation provides insurance and related products and services in the United States.
Read More
Overview
Value
49
Growth
58
Health
50
Management
68
Analyst Opinion
89
Total
63
All Scores Out Of 100
Best Features
- Has a low level of debt
- Liked by analysts
Risk Factors
- Earnings have declined recently
- There is a history of diluting shareholders
- Disliked by Twitter users
- Price-to-earnings ratio of 25.9 is higher than the market average (19.6x)
Market Peers
CI
Key Figures
PE Ratio (TTM)
25.87
Margin Of Safety (DCF)
35.52%
Revenue Growth (5 Year Average)
11.94%
Ratings Consensus
Strong Buy
Share Buybacks
-6.74%
Dividend Yeild (TTM)
1.49%
Valuation
Value Score
49
- ✔ Free-cashflow-yeild of 10.51% is better than the market average (4.7%)
- ✔ Margin-of-safety of 35.52% is better than the market average (17.95%)
- ✔ Estimated intrinsic-value of 451.21 USD is higher than current price ( 352.39 USD)
- ✘ Price-to-earnings ratio of 25.9 is higher than the market average (19.6x)
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 340.6 USD ✔
Current Price: 333 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
25.87x
Free Cashflow Yeild
10.51%
PE/Earnings Growth
0.76
Price/Book
2.10x
Growth
Growth Score
58
- ✔ 5 Year Average Revenue growth of 11.94% is higher than the market average (10.97%)
- ✔ 5 Year Average Earnings growth of 18.12% is higher than the market average (14.48%)
- ✔ 5 Year Average Cashflow growth of 13.06% is higher than the market average (12.35%)
- ✔ Free Cashflow growth has improved this year
- ✘ Revenue growth has slowed this year
- ✘ Earnings growth has slowed this year
Revenue Growth
11.94%
Earnings Growth
18.12%
Cashflow Growth
13.06%
Health
Health Score
50
Altman Z Score
2.30
Piostroski Score
7.00
Debt/Equity
0.69x
Current Assets/Liabilities
2.67x
Free Cashflow/Total Debt
0.24x
Debt/Capital
1.08x
Dividend
Secure Dividend Score
56
- ✔ Dividend is likely safe
- ✔ Long term dividend payout ratio of 7.63% is considered good
- ✔ Payout ratio (TTM) of 38.19% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✘ Dividend yeild of 1.49% is less than the market average (1.85%)
- ✘ Spending a higher percentage of their income on dividends than last 5 years
Dividend Yeild
1.49%
Dividend Growth
3.21%
Payout Ratio (Earnings)
38.19%
Payout Ratio (Cashflow)
14.16%
Management
Management Score
68
- ✔ Has issued new shares to finance growth when share price is high
- ✔ Has returned higher dividends when earnings have risen
- ✔ Return-on-capital-employed of 10.68% is higher than the market average (10%)
- ✘ Has a history of diluting shareholders to finance activity
- ✘ Return-on-equity of 13.88% is lower than the market average (15%)
Average Buybacks/Dilution
-6.74%
Recent Buybacks/Dilution
-13.45%
5 Year Price Volitility
19.95%
Return On Assets
4.33%
Return On Capital Employed
10.68%
Return On Equity
13.88%
Return On Free Cashflow
N/A
Return On Investments
344.20%
Analysts
Analyst Opinion
89
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Cigna Corporation
Currency
USD
Beta
0.65403
Vol Avg
1651325
Ceo
Mr. David Michael Cordani
Cik
0001739940
Cusip
125523100
Exchange
New York Stock Exchange
Full Time Employees
71300
Industry
Healthcare Plans
Sector
Healthcare
Ipo Date
1982-03-31
Address
900 Cottage Grove Road
City
Bloomfield
State
CT
Country
US
Zip
06002
Phone
860 226 6000
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
0
Twitter Sentiment
N/A
Stocktwits Sentiment
N/A